Ankilozan Spondilit, Crohn Hastalığı ve Anti-tümör Nekroz Faktör-alfa Tedavi ile İndüklenen Psoriasis olan Hastada Ustekinumab Tedavisine Dramatik Yanıt
Treatment with anti-tumour necrosis factor-alpha (anti-TNF-α) drugs provides significant improvements in many chronic inflammatory diseases with common pathogenesis, including Crohn’s disease, ankylosing spondylitis and psoriasis. However, during these treatments, paradoxically, cutaneous side effec...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Galenos Yayinevi
2020-12-01
|
Series: | Türk Osteoporoz Dergisi |
Subjects: | |
Online Access: |
http://www.turkosteoporozdergisi.org/archives/archive-detail/article-preview/ankilozan-spondilit-crohn-hastal-ve-anti-tmr-nekro/42968
|
id |
doaj-f2e195a209024ff69e5f2b133f9445eb |
---|---|
record_format |
Article |
spelling |
doaj-f2e195a209024ff69e5f2b133f9445eb2021-01-08T12:23:25ZengGalenos YayineviTürk Osteoporoz Dergisi2147-26532147-26532020-12-0126319720010.4274/tod.galenos.2020.7167713049054Ankilozan Spondilit, Crohn Hastalığı ve Anti-tümör Nekroz Faktör-alfa Tedavi ile İndüklenen Psoriasis olan Hastada Ustekinumab Tedavisine Dramatik YanıtSevilay Kılıç0Hatice Reşorlu1Alper Ekinci2Ayşe Selcen Bulut Keskin3 Çanakkale Onsekiz Mart Üniversitesi Tıp Fakültesi, Dermatoloji Anabilim Dalı, Çanakkale, Türkiye Çanakkale Onsekiz Mart Üniversitesi Tıp Fakültesi, Fiziksel Tıp ve Rehabilitasyon Anabilim Dalı, Çanakkale, Türkiye Çanakkale Onsekiz Mart Üniversitesi Tıp Fakültesi, Dermatoloji Anabilim Dalı, Çanakkale, Türkiye Çanakkale Onsekiz Mart Üniversitesi Tıp Fakültesi, Fiziksel Tıp ve Rehabilitasyon Anabilim Dalı, Çanakkale, Türkiye Treatment with anti-tumour necrosis factor-alpha (anti-TNF-α) drugs provides significant improvements in many chronic inflammatory diseases with common pathogenesis, including Crohn’s disease, ankylosing spondylitis and psoriasis. However, during these treatments, paradoxically, cutaneous side effects such as psoriasis can be seen. Although its pathophysiology is well understood, it is thought that TNF-α blockade triggers locally excessive interferon-α production in predisposed subjects and causes psoriatic lesions. In this case report, we present a 50-year-old female patient with ankylosing spondylitis and Crohn’s disease who used adalimumab and then infliximab and developed psoriasiform lesions due to these drugs. Anti-TNF-α treatment was discontinued, and ustekinumab was started. Psoriasiform rashes improved; disease activity of ankylosing spondylitis and Crohn’s disease was suppressed. Ustekinumab may be a good option to manage ankylosing spondylitis and patients with Crohn’s disease who develop psoriasiform rashes due to anti-TNF-α drugs. http://www.turkosteoporozdergisi.org/archives/archive-detail/article-preview/ankilozan-spondilit-crohn-hastal-ve-anti-tmr-nekro/42968 psoriasiscrohn’s diseaseankylosing spondylitisustekinumab |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Sevilay Kılıç Hatice Reşorlu Alper Ekinci Ayşe Selcen Bulut Keskin |
spellingShingle |
Sevilay Kılıç Hatice Reşorlu Alper Ekinci Ayşe Selcen Bulut Keskin Ankilozan Spondilit, Crohn Hastalığı ve Anti-tümör Nekroz Faktör-alfa Tedavi ile İndüklenen Psoriasis olan Hastada Ustekinumab Tedavisine Dramatik Yanıt Türk Osteoporoz Dergisi psoriasis crohn’s disease ankylosing spondylitis ustekinumab |
author_facet |
Sevilay Kılıç Hatice Reşorlu Alper Ekinci Ayşe Selcen Bulut Keskin |
author_sort |
Sevilay Kılıç |
title |
Ankilozan Spondilit, Crohn Hastalığı ve Anti-tümör Nekroz Faktör-alfa Tedavi ile İndüklenen Psoriasis olan Hastada Ustekinumab Tedavisine Dramatik Yanıt |
title_short |
Ankilozan Spondilit, Crohn Hastalığı ve Anti-tümör Nekroz Faktör-alfa Tedavi ile İndüklenen Psoriasis olan Hastada Ustekinumab Tedavisine Dramatik Yanıt |
title_full |
Ankilozan Spondilit, Crohn Hastalığı ve Anti-tümör Nekroz Faktör-alfa Tedavi ile İndüklenen Psoriasis olan Hastada Ustekinumab Tedavisine Dramatik Yanıt |
title_fullStr |
Ankilozan Spondilit, Crohn Hastalığı ve Anti-tümör Nekroz Faktör-alfa Tedavi ile İndüklenen Psoriasis olan Hastada Ustekinumab Tedavisine Dramatik Yanıt |
title_full_unstemmed |
Ankilozan Spondilit, Crohn Hastalığı ve Anti-tümör Nekroz Faktör-alfa Tedavi ile İndüklenen Psoriasis olan Hastada Ustekinumab Tedavisine Dramatik Yanıt |
title_sort |
ankilozan spondilit, crohn hastalığı ve anti-tümör nekroz faktör-alfa tedavi ile i̇ndüklenen psoriasis olan hastada ustekinumab tedavisine dramatik yanıt |
publisher |
Galenos Yayinevi |
series |
Türk Osteoporoz Dergisi |
issn |
2147-2653 2147-2653 |
publishDate |
2020-12-01 |
description |
Treatment with anti-tumour necrosis factor-alpha (anti-TNF-α) drugs provides significant improvements in many chronic inflammatory diseases with common pathogenesis, including Crohn’s disease, ankylosing spondylitis and psoriasis. However, during these treatments, paradoxically, cutaneous side effects such as psoriasis can be seen. Although its pathophysiology is well understood, it is thought that TNF-α blockade triggers locally excessive interferon-α production in predisposed subjects and causes psoriatic lesions. In this case report, we present a 50-year-old female patient with ankylosing spondylitis and Crohn’s disease who used adalimumab and then infliximab and developed psoriasiform lesions due to these drugs. Anti-TNF-α treatment was discontinued, and ustekinumab was started. Psoriasiform rashes improved; disease activity of ankylosing spondylitis and Crohn’s disease was suppressed. Ustekinumab may be a good option to manage ankylosing spondylitis and patients with Crohn’s disease who develop psoriasiform rashes due to anti-TNF-α drugs. |
topic |
psoriasis crohn’s disease ankylosing spondylitis ustekinumab |
url |
http://www.turkosteoporozdergisi.org/archives/archive-detail/article-preview/ankilozan-spondilit-crohn-hastal-ve-anti-tmr-nekro/42968
|
work_keys_str_mv |
AT sevilaykılıc ankilozanspondilitcrohnhastalıgıveantitumornekrozfaktoralfatedaviileinduklenenpsoriasisolanhastadaustekinumabtedavisinedramatikyanıt AT haticeresorlu ankilozanspondilitcrohnhastalıgıveantitumornekrozfaktoralfatedaviileinduklenenpsoriasisolanhastadaustekinumabtedavisinedramatikyanıt AT alperekinci ankilozanspondilitcrohnhastalıgıveantitumornekrozfaktoralfatedaviileinduklenenpsoriasisolanhastadaustekinumabtedavisinedramatikyanıt AT ayseselcenbulutkeskin ankilozanspondilitcrohnhastalıgıveantitumornekrozfaktoralfatedaviileinduklenenpsoriasisolanhastadaustekinumabtedavisinedramatikyanıt |
_version_ |
1724344561683136512 |